A Fantastic Cancer-Drug Deal
112584
Medarex (Nasdaq: MEDX) is best known for being a leader in antibody technology with its capabilities for generating human antibodies in mice.
751523
A new addition to an already successful drug promises good results for investors.
9936
Big pharmaceutical companies sometimes calculated to the penny the profits that doctors could make from their cancer drugs and shared those estimates with doctors.
586730
Its past success bodes well for its plans for a new blood pressure drug.
243349
This lung cancer drug is not as effective as once hoped.
213457
U.S. scientists have discovered a gene that is the molecular mechanism that enables non-steroidal anti-inflammatory drugs to halt the growth of cancer.
435276
The troubled pharmaceutical company begins to show signs of life.
536698
EU approval opens new markets for the cancer drug that could edge out the competition by lowering overall medical costs.
128005
The new drug benefit guarantees patients access to medicines while giving insurance companies potent tools to control costs.
727207
Australian marine scientists have joined up with an Austrian drug company to develop cancer-fighting medicines from chemicals found in sea sponges and ocean algae.
548970
A drug widely used to treat H.I.V. infection may also be effective in fighting cancer, a new study suggests, and a human trial of the medicine is already under way.
708021
The pharma gives us its quest for bidders.
653679
The EU market welcomes the drugmaker's copy of a treatment for anemia.
106177
Lifestyle may play a big role in how well the latest generation of anti-cancer drugs works, research suggests.
409638
Promising trials for a hepatitis C treatment bode well for the pharmaceutical.
257252
Dogs are receiving groundbreaking drugs or other treatments for cancer, a leading cause of death in older dogs.
354080
The medicine is the first product of an innovative collaboration between a drug company and a medical charity.